Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 6359730, 19 pages
https://doi.org/10.1155/2017/6359730
Review Article

The Use of Omic Technologies Applied to Traditional Chinese Medicine Research

1Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong
2Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong
3Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong

Correspondence should be addressed to Man-Sau Wong; kh.ude.uylop@gnow.uas-nam

Received 28 July 2016; Revised 23 October 2016; Accepted 24 October 2016; Published 31 January 2017

Academic Editor: Fabio Firenzuoli

Copyright © 2017 Dalinda Isabel Sánchez-Vidaña et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Harvey, R. Edrada-Ebel, and R. J. Quinn, “The re-emergence of natural products for drug discovery in the genomics era,” Nature Reviews Drug Discovery, vol. 14, no. 2, pp. 111–129, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Patwardhan, D. Warude, P. Pushpangadan, and N. Bhatt, “Ayurveda and traditional Chinese medicine: a comparative overview,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 4, pp. 465–473, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Newman and G. M. Cragg, “Natural products as sources of new drugs over the 30 years from 1981 to 2010,” Journal of Natural Products, vol. 75, no. 3, pp. 311–335, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. Newman and G. M. Cragg, “Natural products as sources of new drugs over the last 25 years,” Journal of Natural Products, vol. 70, no. 3, pp. 461–477, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. T.-P. Fan, G. Deal, H.-L. Koo et al., “Future development of global regulations of Chinese herbal products,” Journal of Ethnopharmacology, vol. 140, no. 3, pp. 568–586, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Yuan and Y. Lin, “Traditional Chinese medicine: an approach to scientific proof and clinical validation,” Pharmacology and Therapeutics, vol. 86, no. 2, pp. 191–198, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. WHO, WHO Traditional Medicine Strategy 2014–2023, World Health Organization, Genève, Switzerland, 2013.
  8. W.-Y. Jiang, “Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science,” Trends in Pharmacological Sciences, vol. 26, no. 11, pp. 558–563, 2005. View at Publisher · View at Google Scholar
  9. M. V. Olson, “The human genome project: a player's perspective,” Journal of Molecular Biology, vol. 319, no. 4, pp. 931–942, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. S. K. Chanda and J. S. Caldwell, “Fulfilling the promise: drug discovery in the post-genomic era,” Drug Discovery Today, vol. 8, no. 4, pp. 168–174, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. F. S. Collins, E. D. Green, A. E. Guttmacher, and M. S. Guyer, “A vision for the future of genomics research,” Nature, vol. 422, no. 6934, pp. 835–847, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Pelkonen, M. Pasanen, J. C. Lindon et al., “Omics and its potential impact on R&D and regulation of complex herbal products,” Journal of Ethnopharmacology, vol. 140, no. 3, pp. 587–593, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Reiss, “Drug discovery of the future: the implications of the human genome project,” Trends in Biotechnology, vol. 19, no. 12, pp. 496–499, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. S.-K. Yan, R.-H. Liu, H.-Z. Jin et al., “‘Omics’ in pharmaceutical research: overview, applications, challenges, and future perspectives,” Chinese Journal of Natural Medicines, vol. 13, no. 1, pp. 3–21, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Wang, A. Zhang, H. Sun, and P. Wang, “Systems biology technologies enable personalized traditional chinese medicine: a systematic review,” American Journal of Chinese Medicine, vol. 40, no. 6, pp. 1109–1122, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Buriani, M. L. Garcia-Bermejo, E. Bosisio et al., “Omic techniques in systems biology approaches to traditional Chinese medicine research: present and future,” Journal of Ethnopharmacology, vol. 140, no. 3, pp. 535–544, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. Z.-Y. Su, L. Shu, J. H. Lee et al., “Perspective on Nrf2, epigenomics and cancer stem cells in cancer chemoprevention using dietary phytochemicals and traditional Chinese medicines,” Progress in Chemistry, vol. 25, no. 9, pp. 1526–1543, 2013. View at Google Scholar · View at Scopus
  18. H. Li, M. Zhou, A. Zhao, and W. Jia, “Traditional Chinese medicine: balancing the gut ecosystem,” Phytotherapy Research, vol. 23, no. 9, pp. 1332–1335, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Gao, D. Weisman, J. Lan, N. Gou, and A. Z. Gu, “Toxicity mechanisms identification via gene set enrichment analysis of time-series toxicogenomics data: impact of time and concentration,” Environmental Science and Technology, vol. 49, no. 7, pp. 4618–4626, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. D. Waters and J. M. Fostel, “Toxicogenomics and systems toxicology: aims and prospects,” Nature Reviews Genetics, vol. 5, no. 12, pp. 936–948, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. A. K. Daly, “Pharmacogenomics of adverse drug reactions,” Genome Medicine, vol. 5, article 5, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Shahabi and M.-P. Dubé, “Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice,” International Journal of Cardiology, vol. 184, no. 1, pp. 772–795, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. J. Kang, “Herbogenomics: from traditional Chinese medicine to novel therapeutics,” Experimental Biology and Medicine, vol. 233, no. 9, pp. 1059–1065, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. K. L. Denzler, R. Waters, B. L. Jacobs, Y. Rochon, and J. O. Langland, “Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals,” PloS one, vol. 5, no. 9, Article ID e12561, 2010. View at Google Scholar · View at Scopus
  25. R. M. Twyman, Principles of Proteomics, Garland Science, New York, NY, USA; Taylor Francis Group LLC, Boca Raton, Fla, USA, 2nd edition, 2014.
  26. P. Cutler and H. Voshol, “Proteomics in pharmaceutical research and development,” Proteomics—Clinical Applications, vol. 9, no. 7-8, pp. 643–650, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. I. M. Cristea, S. J. Gaskell, and A. D. Whetton, “Proteomics techniques and their application to hematology,” Blood, vol. 103, no. 10, pp. 3624–3634, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Li, L.-P. Yang, and Y.-W. Gong, “Application of systems biology technology in research of traditional Chinese medicine,” Journal of Traditional Chinese Medicine, vol. 29, no. 2, pp. 153–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Pagel, S. Loroch, A. Sickmann, and R. P. Zahedi, “Current strategies and findings in clinically relevant post-translational modification-specific proteomics,” Expert Review of Proteomics, vol. 12, no. 3, pp. 235–253, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. R. B. Van Breemen, H. H. S. Fong, and N. R. Farnsworth, “Ensuring the safety of botanical dietary supplements,” American Journal of Clinical Nutrition, vol. 87, no. 2, pp. 509S–5013S, 2008. View at Google Scholar · View at Scopus
  31. M. Bantscheff and G. Drewes, “Chemoproteomic approaches to drug target identification and drug profiling,” Bioorganic and Medicinal Chemistry, vol. 20, no. 6, pp. 1973–1978, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Bulman, M. Neagu, and C. Constantin, “Immunomics in skin cancer—improvement in diagnosis, prognosis and therapy monitoring,” Current Proteomics, vol. 10, no. 3, pp. 202–217, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. H.-D. Ma, Y.-R. Deng, Z. Tian, and Z.-X. Lian, “Traditional Chinese medicine and immune regulation,” Clinical Reviews in Allergy and Immunology, vol. 44, no. 3, pp. 229–241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Ohashi, M. Hasegawa, K. Wakimoto, and E. Miyamoto-Sato, “Next-generation technologies for multiomics approaches including interactome sequencing,” BioMed Research International, vol. 2015, Article ID 104209, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Ulrich-Merzenich, H. Zeitler, D. Jobst, D. Panek, H. Vetter, and H. Wagner, “Application of the “-Omic-” technologies in phytomedicine,” Phytomedicine, vol. 14, no. 1, pp. 70–82, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Kaddurah-Daouk and R. M. Weinshilboum, “Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology,” Clinical Pharmacology and Therapeutics, vol. 95, no. 2, pp. 154–167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Bouhifd, T. Hartung, H. T. Hogberg, A. Kleensang, and L. Zhao, “Review: toxicometabolomics,” Journal of Applied Toxicology, vol. 33, no. 12, pp. 1365–1383, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Zhang, H. Wu, P. Liao, X. Li, J. Ni, and F. Pei, “NMR-based metabonomic study on the subacute toxicity of aristolochic acid in rats,” Food and Chemical Toxicology, vol. 44, no. 7, pp. 1006–1014, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Ni, M. Su, Y. Qiu et al., “Metabolic profiling using combined GC-MS and LC-MS provides a systems understanding of aristolochic acid-induced nephrotoxicity in rat,” FEBS Letters, vol. 581, no. 4, pp. 707–711, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. W. Chan, K.-C. Lee, N. Liu, R. N. S. Wong, H. Liu, and Z. Cai, “Liquid chromatography/mass spectrometry for metabonomics investigation of the biochemical effects induced by aristolochic acid in rats: the use of information-dependent acquisition for biomarker identification,” Rapid Communications in Mass Spectrometry, vol. 22, no. 6, pp. 873–880, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Liu, Y. Xiao, H.-C. Gao, J. Ren, and D.-H. Lin, “Metabonomic study of aristolochic acid I-induced acute renal toxicity urine at female and male C57BL/6J Mice based on H-1 NMR,” Gaodeng Xuexiao Huaxue Xuebao/Chemical Journal of Chinese Universities, vol. 31, no. 5, pp. 927–932, 2010. View at Google Scholar · View at Scopus
  42. P. Guo, J. Wang, G. Dong et al., “NMR-based metabolomics approach to study the chronic toxicity of crude ricin from castor bean kernels on rats,” Molecular BioSystems, vol. 10, no. 9, pp. 2426–2440, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Aa, F. Shao, G. Wang et al., “Gas chromatography time-of-flight mass spectrometry based metabolomic approach to evaluating toxicity of triptolide,” Metabolomics, vol. 7, no. 2, pp. 217–225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. C. C. Teo, W. P. K. Chong, E. Tan, N. B. Basri, Z. J. Low, and Y. S. Ho, “Advances in sample preparation and analytical techniques for lipidomics study of clinical samples,” TrAC—Trends in Analytical Chemistry, vol. 66, pp. 1–18, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Astarita and M. Ollero, “Lipidomics: an evolving discipline in molecular sciences,” International Journal of Molecular Sciences, vol. 16, no. 4, pp. 7748–7752, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. M. D. Del Castillo, N. Martinez-Saez, M. Amigo-Benavent, and J. M. Silvan, “Phytochemomics and other omics for permitting health claims made on foods,” Food Research International, vol. 54, no. 1, pp. 1237–1249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. X. Wang, A. Zhang, and H. Sun, “Future perspectives of Chinese medical formulae: chinmedomics as an effector,” OMICS A Journal of Integrative Biology, vol. 16, no. 7-8, pp. 414–421, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. A.-H. Zhang, H. Sun, G.-L. Yan, P. Wang, Y. Han, and X.-J. Wang, “Chinmedomics: a new strategy for research of traditional Chinese medicine,” Zhongguo Zhong Yao Za Zhi, vol. 40, no. 4, pp. 569–576, 2015. View at Google Scholar · View at Scopus
  49. X. Wang, A. Zhang, and H. Sun, Eds., Chinmedomics: The Integration of Serum Pharmacochemistry and Metabolomics to Elucidate the Scientific Value of Traditional Chinese Medicine, Mica Haley, 1st edition, 2015.
  50. Y. Ogra, “Development of metallomics research on environmental toxicology,” Yakugaku Zasshi journal of the Pharmaceutical Society of Japan, vol. 135, no. 2, pp. 307–314, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. I. Baxter, “Should we treat the ionome as a combination of individual elements, or should we be deriving novel combined traits?” Journal of Experimental Botany, vol. 66, no. 8, pp. 2127–2131, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. D. E. Salt, I. Baxter, and B. Lahner, “Ionomics and the study of the plant ionome,” Annual Review of Plant Biology, vol. 59, pp. 709–733, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. D. Wu, Q. Shen, S. Cai, Z.-H. Chen, F. Dai, and G. Zhang, “Ionomic responses and correlations between elements and metabolites under salt stress in wild and cultivated barley,” Plant and Cell Physiology, vol. 54, no. 12, pp. 1976–1988, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Hoehndorf, P. N. Schofield, and G. V. Gkoutos, “Analysis of the human diseasome using phenotype similarity between common, genetic, and infectious diseases,” Scientific Reports, vol. 5, Article ID 10888, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. A. A. Monte, C. Brocker, D. W. Nebert, F. J. Gonzalez, D. C. Thompson, and V. Vasiliou, “Improved drug therapy: triangulating phenomics with genomics and metabolomics,” Human Genomics, vol. 8, article 16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Valet, “Cytomics: an entry to biomedical cell systems biology,” Cytometry Part A, vol. 63, no. 2, pp. 67–68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Lee, “Genetically engineered mouse models for drug development and preclinical trials,” Biomolecules and Therapeutics, vol. 22, no. 4, pp. 267–274, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Baba, “Development of novel biomedicine based on genome science,” European Journal of Pharmaceutical Sciences, vol. 13, no. 1, pp. 3–4, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. G.-J. B. van Ommen, “The Human Genome Project and the future of diagnostics, treatment and prevention,” Journal of Inherited Metabolic Disease, vol. 25, no. 3, pp. 183–188, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. J.-F. Wang and D.-Q. Wei, “Role of structural bioinformatics and traditional Chinese medicine databases in pharmacogenomics,” Pharmacogenomics, vol. 10, no. 8, pp. 1213–1215, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. W. C.-S. Cho, “Application of proteomics in Chinese medicine research,” American Journal of Chinese Medicine, vol. 35, no. 6, pp. 911–922, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. C. M. Carnielli, F. V. Winck, and A. F. P. Leme, “Functional annotation and biological interpretation of proteomics data,” Biochimica et Biophysica Acta—Proteins and Proteomics, vol. 1854, no. 1, pp. 46–54, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. Q.-R. Li, Z.-B. Ning, X.-L. Yang, J.-R. Wu, and R. Zeng, “Complementary workflow for global phosphoproteome analysis,” Electrophoresis, vol. 33, no. 22, pp. 3291–3298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Cieśla, T. Fraczyk, and W. Rode, “Phosphorylation of basic amino acid residues in proteins: important but easily missed,” Acta Biochimica Polonica, vol. 58, no. 2, pp. 137–148, 2011. View at Google Scholar · View at Scopus
  65. A. Taylor, M. P. Day, S. Hill, and J. Marshall, “Atomic spectrometry update: review of advances in the analysis of clinical and biological materials, foods and beverages,” Journal of Analytical Atomic Spectrometry, vol. 29, no. 3, pp. 386–426, 2014. View at Publisher · View at Google Scholar
  66. R. Djingova, V. Mihaylova, V. Lyubomirova, and D. L. Tsalev, “Multielement analytical spectroscopy in plant ionomics research,” Applied Spectroscopy Reviews, vol. 48, no. 5, pp. 384–424, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. T. M. Kalyankar, S. J. Wadher, S. S. Dange, M. S. Attar, and A. M. Pattewar, “Analysis of herbal drugs: a review,” Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry, vol. 1, article 12, 2014. View at Google Scholar
  68. Z. Qu, J. Cui, Y. Harata-Lee et al., “Identification of candidate anti-cancer molecular mechanisms of compound kushen injection using functional genomics,” Oncotarget, 2016. View at Publisher · View at Google Scholar
  69. H.-M. Cheng, C.-C. Li, C. Y.-C. Chen et al., “Application of bioactivity database of Chinese herbal medicine on the therapeutic prediction, drug development, and safety evaluation,” Journal of Ethnopharmacology, vol. 132, no. 2, pp. 429–437, 2010. View at Publisher · View at Google Scholar
  70. Y. Gu, Y. Zhang, X. Shi et al., “Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics,” Talanta, vol. 81, no. 3, pp. 766–772, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Miao, Y.-H. Zhao, N. D. Vaziri et al., “Lipidomics biomarkers of diet-induced hyperlipidemia and its treatment with poria cocos,” Journal of Agricultural and Food Chemistry, vol. 64, no. 4, pp. 969–979, 2016. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Amigo-Benavent, A. Clemente, S. Caira, P. Stiuso, P. Ferranti, and M. D. Del Castillo, “Use of phytochemomics to evaluate the bioavailability and bioactivity of antioxidant peptides of soybean β-conglycinin,” Electrophoresis, vol. 35, no. 11, pp. 1582–1589, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. X. Wang, H. Lv, H. Sun et al., “Metabolic urinary profiling of alcohol hepatotoxicity and intervention effects of Yin Chen Hao Tang in rats using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 48, no. 4, pp. 1161–1168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. X.-Z. Li, S.-N. Zhang, K.-X. Wang, S.-M. Liu, and F. Lu, “ITRAQ-based quantitative proteomics study on the neuroprotective effects of extract of Acanthopanax senticosus harm on SH-SY5Y cells overexpressing A53T mutant α-synuclein,” Neurochemistry International, vol. 72, no. 1, pp. 37–47, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. Cui, C. Rong, J. Wang et al., “Mechanism-based anti-anxiety effects of polysaccharides extracted from Shudihuang (radix rehmanniae Preparata) by two-dimensional electrophoresis analysis in rat hippocampus proteins,” Journal of Traditional Chinese Medicine, vol. 33, no. 4, pp. 524–530, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. H.-Y. Qi, L. Li, J. Yu et al., “Proteomic identification of Nrf2-mediated phase II enzymes critical for protection of Tao Hong Si Wu decoction against oxygen glucose deprivation injury in PC12 cells,” Evidence-based Complementary and Alternative Medicine, vol. 2014, Article ID 945814, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. Y.-Y. Zhao, H.-T. Li, Y.-L. Feng, X. Bai, and R.-C. Lin, “Urinary metabonomic study of the surface layer of Poria cocos as an effective treatment for chronic renal injury in rats,” Journal of Ethnopharmacology, vol. 148, no. 2, pp. 403–410, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. G. Dong, D. Wei, J. Wang et al., “Study of the cardiotoxicity of venenum bufonis in rats using an 1H NMR-based metabolomics approach,” PLoS ONE, vol. 10, no. 3, Article ID e0119515, 2015. View at Publisher · View at Google Scholar · View at Scopus
  79. B. Yan, Y. Deng, J. Hou et al., “UHPLC-LTQ-Orbitrap MS combined with spike-in method for plasma metabonomics analysis of acute myocardial ischemia rats and pretreatment effect of Danqi Tongmai tablet,” Molecular BioSystems, vol. 11, no. 2, pp. 486–496, 2015. View at Publisher · View at Google Scholar · View at Scopus
  80. Y.-T. Liu, J.-B. Peng, H.-M. Jia et al., “UPLC-Q/TOF MS standardized Chinese formula Xin-Ke-Shu for the treatment of atherosclerosis in a rabbit model,” Phytomedicine, vol. 21, no. 11, pp. 1364–1372, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. Y.-T. Liu, J.-B. Peng, H.-M. Jia, H.-W. Zhang, G. Ding, and Z.-M. Zou, “Urinary metabonomic evaluation of the therapeutic effect of traditional Chinese medicine Xin-Ke-Shu against atherosclerosis rabbits using UPLC-Q/TOF MS,” Chemometrics and Intelligent Laboratory Systems, vol. 136, pp. 104–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. W. Li, Y. Tang, J. Guo et al., “Comparative metabolomics analysis on hematopoietic functions of herb pair Gui-Xiong by ultra-high-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry and pattern recognition approach,” Journal of Chromatography A, vol. 1346, pp. 49–56, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Zhang, P. Fu, B. Ke et al., “Metabolomic analysis of biochemical changes in the plasma and urine of collagen-induced arthritis in rats after treatment with Huang-Lian-Jie-Du-Tang,” Journal of Ethnopharmacology, vol. 154, no. 1, pp. 55–64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. X. Ding, J. Hu, C. Wen, Z. Ding, L. Yao, and Y. Fan, “Rapid resolution liquid chromatography coupled with quadrupole time-of-flight mass spectrometry-based metabolomics approach to study the effects of jieduquyuziyin prescription on systemic lupus erythematosus,” PLoS ONE, vol. 9, no. 2, Article ID e88223, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. L.-L. Lin, C.-R. Hsia, C.-L. Hsu, H.-C. Huang, and H.-F. Juan, “Integrating transcriptomics and proteomics to show that tanshinone IIA suppresses cell growth by blocking glucose metabolism in gastric cancer cells,” BMC Genomics, vol. 16, article 41, 2015. View at Publisher · View at Google Scholar · View at Scopus
  86. O. Kadioglu, N. S. Kermani, G. Kelter et al., “Pharmacogenomics of cantharidin in tumor cells,” Biochemical Pharmacology, vol. 87, no. 3, pp. 399–409, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Sertel, T. Eichhorn, C. H. Simon, P. K. Plinkert, S. W. Johnson, and T. Efferth, “Pharmacogenomic identification of c-Myc/Max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines,” Molecules, vol. 15, no. 4, pp. 2886–2910, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. H.-W. Wang, K.-T. Liou, Y.-H. Wang et al., “Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice,” Journal of Ethnopharmacology, vol. 138, no. 1, pp. 22–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Liu, J. Fan, S. Wang et al., “Transcriptional profiling of Chinese medicinal formula Si-Wu-Tang on breast cancer cells reveals phytoestrogenic activity,” BMC Complementary and Alternative Medicine, vol. 13, article 11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. Y. Hu, X. Chen, H. Lin, Y. Hu, and X. Mu, “Study on the antiendotoxin action of Pulsatillae Decoction using an Affymetrix rat genome array,” Cellular Immunology, vol. 257, no. 1-2, pp. 32–37, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. W. J. Bei, J. Guo, H. Y. Wu, and Y. Cao, “Lipid-regulating effect of traditional chinese medicine: mechanisms of actions,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 970635, 10 pages, 2012. View at Publisher · View at Google Scholar
  92. P. Y. K. Yue, N. K. Mak, Y. K. Cheng et al., “Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides,” Chinese Medicine, vol. 2, article 6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. S. P. Li, J. Zhao, and B. Yang, “Strategies for quality control of Chinese medicines,” Journal of Pharmaceutical and Biomedical Analysis, vol. 55, no. 4, pp. 802–809, 2011. View at Publisher · View at Google Scholar
  94. S. A. Jordan, D. G. Cunningham, and R. J. Marles, “Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment,” Toxicology and Applied Pharmacology, vol. 243, no. 2, pp. 198–216, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. N. Sahoo, P. Manchikanti, and S. Dey, “Herbal drugs: standards and regulation,” Fitoterapia, vol. 81, no. 6, pp. 462–471, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. P. Claeson, “Requirements on efficacy of herbal medicinal products,” Journal of Ethnopharmacology, vol. 158, pp. 463–466, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. Y. Jiang, B. David, P. Tu, and Y. Barbin, “Recent analytical approaches in quality control of traditional Chinese medicines—a review,” Analytica Chimica Acta, vol. 657, no. 1, pp. 9–18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. B. H. Kroes, “The legal framework governing the quality of (traditional) herbal medicinal products in the European Union,” Journal of Ethnopharmacology, vol. 158, pp. 449–453, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. F. Van Der Kooy, F. Maltese, H. C. Young, K. K. Hye, and R. Verpoorte, “Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting,” Planta Medica, vol. 75, no. 7, pp. 763–775, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. Y. Liu, J. Liu, P. Yin, M. Gao, C. Deng, and X. Zhang, “High throughput identification of components from traditional Chinese medicine herbs by utilizing graphene or graphene oxide as MALDI-TOF-MS matrix,” Journal of mass spectrometry : JMS, vol. 46, no. 8, pp. 804–815, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. D. Steinmann and M. Ganzera, “Recent advances on HPLC/MS in medicinal plant analysis,” Journal of Pharmaceutical and Biomedical Analysis, vol. 55, no. 4, pp. 744–757, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. X.-Y. Song, Y.-D. Li, Y.-P. Shi, L. Jin, and J. Chen, “Quality control of traditional Chinese medicines: a review,” Chinese Journal of Natural Medicines, vol. 11, no. 6, pp. 596–607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Chen, J. Song, C. Sun et al., “Herbal genomics: examining the biology of traditional medicines,” Science, vol. 347, no. 6219, pp. S27–S29, 2015. View at Publisher · View at Google Scholar
  104. M. Jiang, Y. Jiao, Y. Wang et al., “Quantitative profiling of polar metabolites in herbal medicine injections for multivariate statistical evaluation based on independence principal component analysis,” PLoS ONE, vol. 9, no. 8, Article ID e105412, 2014. View at Publisher · View at Google Scholar · View at Scopus
  105. P. H. Chan, W. L. Zhang, C. Y. Cheung, K. W. K. Tsim, and H. Lam, “Quality control of Danggui Buxue Tang, a traditional Chinese medicine decoction, by 1H-NMR metabolic profiling,” Evidence-based Complementary and Alternative Medicine, vol. 2014, Article ID 567893, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  106. Y. Wang, S. He, X. Cheng, Y. Lu, Y. Zou, and Q. Zhang, “UPLC–Q-TOF-MS/MS fingerprinting of Traditional Chinese Formula SiJunZiTangnZiTang,” Journal of Pharmaceutical and Biomedical Analysis, vol. 80, pp. 24–33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  107. F. Firenzuoli and L. Gori, “Herbal medicine today: clinical and research issues,” Evidence-Based Complementary and Alternative Medicine, vol. 4, no. S1, pp. 37–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. J. Wang, R. van der Heijden, S. Spruit et al., “Quality and safety of Chinese herbal medicines guided by a systems biology perspective,” Journal of Ethnopharmacology, vol. 126, no. 1, pp. 31–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. Y.-N. Song, G.-B. Zhang, Y.-Y. Zhang, and S.-B. Su, “Clinical applications of omics technologies on Zheng differentiation research in traditional Chinese medicine,” Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 989618, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  110. T. Bottcher, M. Pitscheider, and S. A. Sieber, “Natural products and their biological targets: proteomic and metabolomic labeling strategies,” Angew Chemie, vol. 49, no. 15, pp. 2680–2698, 2010. View at Publisher · View at Google Scholar
  111. S. Camerini and P. Mauri, “The role of protein and peptide separation before mass spectrometry analysis in clinical proteomics,” Journal of Chromatography A, vol. 1381, pp. 1–12, 2015. View at Publisher · View at Google Scholar · View at Scopus
  112. K.-W. Cheng, C.-C. Wong, M. Wang, Q.-Y. He, and F. Chen, “Identification and characterization of molecular targets of natural products by mass spectrometry,” Mass Spectrometry Reviews, vol. 29, no. 1, pp. 126–155, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. J. Huang, F. Wang, M. Ye, and H. Zou, “Enrichment and separation techniques for large-scale proteomics analysis of the protein post-translational modifications,” Journal of Chromatography A, vol. 1372, pp. 1–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  114. L. Beltran and P. R. Cutillas, “Advances in phosphopeptide enrichment techniques for phosphoproteomics,” Amino Acids, vol. 43, no. 3, pp. 1009–1024, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. J. A. J. Jaros, P. C. Guest, H. Ramoune et al., “Clinical use of phosphorylated proteins in blood serum analysed by immobilised metal ion affinity chromatography and mass spectrometry,” Journal of Proteomics, vol. 76, pp. 36–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  116. L.-F. Shyur and N.-S. Yang, “Metabolomics for phytomedicine research and drug development,” Current Opinion in Chemical Biology, vol. 12, no. 1, pp. 66–71, 2008. View at Publisher · View at Google Scholar · View at Scopus
  117. J. Wang, X. Peng, W. Peng, and F.-X. Wu, “Dynamic protein interaction network construction and applications,” Proteomics, vol. 14, no. 4-5, pp. 338–352, 2014. View at Publisher · View at Google Scholar · View at Scopus
  118. Y.-Y. Zhao and R.-C. Lin, “UPLC-MSE application in disease biomarker discovery: the discoveries in proteomics to metabolomics,” Chemico-Biological Interactions, vol. 215, pp. 7–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  119. Y.-Y. Zhao, Y.-L. Feng, X. Bai, X.-J. Tan, R.-C. Lin, and Q. Mei, “Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism,” PLoS ONE, vol. 8, no. 3, Article ID e59617, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. Y.-Y. Zhao, H. Chen, T. Tian et al., “A pharmaco-metabonomic study on chronic kidney disease and therapeutic effect of Ergone by UPLC-QTOF/HDMS,” PLOS ONE, vol. 9, no. 12, Article ID e115467, 2014. View at Publisher · View at Google Scholar · View at Scopus
  121. Z.-H. Zhang, F. Wei, N. D. Vaziri et al., “Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis,” Scientific Reports, vol. 5, article no. 14472, 2015. View at Publisher · View at Google Scholar · View at Scopus
  122. J.-S. Tian, G.-J. Peng, Y.-F. Wu et al., “A GC-MS urinary quantitative metabolomics analysis in depressed patients treated with TCM formula of Xiaoyaosan,” Journal of Chromatography B, vol. 1026, pp. 227–235, 2016. View at Publisher · View at Google Scholar
  123. A. Zhang, H. Sun, and X. Wang, “Recent highlights of metabolomics for Traditional Chinese Medicine,” Pharmazie, vol. 67, no. 8, pp. 667–675, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. S.-S. Li, “The Proteomics: a new tool for Chinese medicine research,” American Journal of Chinese Medicine, vol. 35, no. 6, p. 923, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. Y. Quan, B. Li, Y.-M. Sun, and H.-Y. Zhang, “Elucidating pharmacological mechanisms of natural medicines by biclustering analysis of the gene expression profile: A Case Study On Curcumin and Si-Wu-Tang,” International Journal of Molecular Sciences, vol. 16, no. 1, pp. 510–520, 2015. View at Publisher · View at Google Scholar · View at Scopus
  126. H. Y. Fang, S. B. Chen, D. J. Guo, S. Y. Pan, and Z. L. Yu, “Proteomic identification of differentially expressed proteins in curcumin-treated MCF-7 cells,” Phytomedicine, vol. 18, no. 8-9, pp. 697–703, 2011. View at Publisher · View at Google Scholar · View at Scopus
  127. X. Z. Cai, W. Y. Huang, Y. Qiao et al., “Inhibitory effects of curcumin on gastric cancer cells: a proteomic study of molecular targets,” Phytomedicine, vol. 20, no. 6, pp. 495–505, 2013. View at Publisher · View at Google Scholar · View at Scopus
  128. Y. Lao, X. Wang, N. Xu, H. Zhang, and H. Xu, “Application of proteomics to determine the mechanism of action of traditional Chinese medicine remedies,” Journal of Ethnopharmacology, vol. 155, no. 1, pp. 1–8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  129. D.-F. Wei, Y.-X. Wei, W.-D. Cheng et al., “Proteomic analysis of the effect of triterpenes from Patrinia heterophylla on leukemia K562 cells,” Journal of Ethnopharmacology, vol. 144, no. 3, pp. 576–583, 2012. View at Publisher · View at Google Scholar · View at Scopus
  130. H. Sun, A. Zhang, G. Yan et al., “Proteomics study on the hepatoprotective effects of traditional Chinese medicine formulae Yin-Chen-Hao-Tang by a combination of two-dimensional polyacrylamide gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 75, pp. 173–179, 2013. View at Publisher · View at Google Scholar · View at Scopus
  131. H.-Y. Lo, C.-C. Li, H.-C. Huang, L.-J. Lin, C.-Y. Hsiang, and T.-Y. Ho, “Application of transcriptomics in Chinese herbal medicine studies,” Journal of Traditional and Complementary Medicine, vol. 2, no. 2, pp. 105–114, 2012. View at Publisher · View at Google Scholar · View at Scopus